Multiple Immune Features-Based Signature for Predicting Recurrence and Survival of Inoperable LA-NSCLC Patients

Abstract

Introduction The immune status of the tumor microenvironment is extremely complex. One single immune feature cannot reflect the integral immune status, and its prognostic value was limited. We postulated that the immune signature based on multiple immuno-features could markedly improve the prediction of post-chemoradiotherapeutic survival in inoperable locally advanced non-small-cell lung cancer (LA-NSCLC) patients. Methods In this study, 100 patients who were diagnosed as having inoperable LA-NSCLC between January 2005 and January 2016 were analyzed. A five immune features-based signature was then constructed using the nested repeat 10-fold cross validation with least absolute shrinkage and selection operator (LASSO) Cox regression model. Nomograms were then established for predicting prognosis. Results The immune signature combining five immuno-features was significantly associated with overall survival (OS) and progression-free survival (PFS) ( P = 0.002 and P = 0.014, respectively) in patients with inoperable LA-NSCLC, and at a cutoff of −0.05 stratified patients into two groups with 5-year OS rates of 39.8 and 8.8%, and 2-year PFS rates of 22.2 and 5.5% for the high- and low-immune signature groups, respectively. Integrating immune signature, we proposed predictive nomograms that were better than the traditional TNM staging system in terms of discriminating ability (OS: 0.692 vs. 0.588; PFS: 0.672 vs. 0.586, respectively) or net weight classification (OS: 32.96%; PFS: 9.22%), suggesting that the immune signature plays a significant role in improving the prognostic value. Conclusion Multiple immune features-based immune signature could effectively predict recurrence and survival of inoperable LA-NSCLC patients and complemented the prognostic value of the TNM staging system.

Differentiating Origins of Outflow Tract Ventricular Arrhythmias: The Correction of Transitional Zone Index Is Not Superior to the Original One

“…Calibration curve determines the consistent degree of fit between actual and predicted values. The reference line of the calibration curve is 45 degree and indicates perfect calibration [ 11 ]. As shown in Figure 5 , the fitness of TZI (left panel), which is closer to the 45-degree diagonal, is better than that of CTZI (right panel).…”

A Novel Stool Methylation Test for the Non-Invasive Screening of Gastric and Colorectal Cancer

“…Because the DNA of tumor cells that shed stool cannot contain a single gene, the sensitivity and specificity of single gene methylation has not reached a very satisfactory level. Combined multitarget detection has become a common method to improve detection sensitivity ( 25 , 38 – 41 ). A previous study reported that the sensitivity of the stool DNA methylation test using single and multiple genes was 48% and 77.8%, and the specificity was 97% and 92.7%, respectively ( 42 ).…”

Comprehensive analysis of tumor microenvironment landscape and potential therapeutic agents based on tumor-infiltrating immune cells in colorectal cancer

“…An emerging study reported the immune-excluded phenotype exits a su cient amount of immune cell but could not completely elicit anti-tumor immune responses since immune cells remain in the stroma surrounding the tumor cell nest instead of penetrating its substance (43,44). The TIIC cluster C was de ned as the immune-desert phenotype characterized by immune suppression, which means the immune tolerance and escape, decreasing in ltration of lymphocytes and lacking activated priming T cells (45). Meanwhile, we found that TIIC cluster C had a highest stromal score, which is widely considered to be positively associated with the TAMs and resting DCs, the results indicated that a humoral immune response in immune-desert phenotype (46, 47).…”